News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
135 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (17234)
Month
January (2936)
February (2968)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
2 (13)
3 (111)
4 (147)
5 (162)
6 (150)
7 (96)
9 (24)
10 (101)
11 (117)
12 (135)
13 (125)
14 (151)
17 (94)
18 (131)
19 (207)
20 (168)
21 (96)
24 (160)
25 (182)
26 (291)
27 (213)
28 (94)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
9
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
Funding
Abcuro Secures $200 Million Series C to Push Rare Muscle Disease Treatment
The Boston-area company’s previous raises were also aimed at getting its investigational antibody treatment for inclusion body myositis through clinical trials. Now, Abcuro is eyeing a regulatory submission and potential launch.
February 12, 2025
·
1 min read
·
Dan Samorodnitsky
Job Trends
2024 Q4 Job Market Report: Biopharma Job Postings Slowed as Layoffs Continued
Year-over-year
BioSpace
data show there were fewer job postings live on the website in the fourth quarter of 2024, and the decrease was higher than the third quarter’s drop.
February 12, 2025
·
3 min read
·
Angela Gabriel
Press Releases
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 12, 2025
·
3 min read
Press Releases
Gilead Sciences Announces 2.6 Percent Increase in First Quarter 2025 Dividend
February 12, 2025
·
1 min read
Press Releases
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
February 12, 2025
·
16 min read
Press Releases
Edwards Lifesciences Reports Fourth Quarter Results
February 12, 2025
·
19 min read
Press Releases
Lion TCR’s Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
February 12, 2025
·
5 min read
Press Releases
GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy at the Conclusion of the REFLECT Study
February 12, 2025
·
9 min read
Press Releases
Biolog Purchases Anaerobe Systems, Its Third Acquisition, Becoming the Knowledge Leader in Microbiology Research and Clinical Sample Prep
February 12, 2025
·
4 min read
Press Releases
New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3
February 12, 2025
·
6 min read
Previous
2 of 14
Next
